Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1314
Full metadata record
DC FieldValueLanguage
dc.contributor.authorREG NO. BM0119007-
dc.date.accessioned2023-03-21T13:18:54Z-
dc.date.available2023-03-21T13:18:54Z-
dc.date.issued2022-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1314-
dc.description.abstractBackground and objectives: Deferiprone when used in combination with Deferasirox, has proven efficacy for reducing serum ferritin levels and the prevention and control of iron overload. This study is aimed at assessing the efficacy of combination therapy with oral iron chelators (Deferasirox and Deferiprone) in children with transfusion-dependent Beta-thalassemia using Echocardiography and Tissue Doppler Imaging.en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectBeta thalassemia; Combination oral chelation; Tissue Doppler Imaging; Echocardiography; Deferiproneen_US
dc.titleEfficacy Of Combination Therapy With Oral Iron Chelators In Children With Transfusion Dependant B-Thalassemia Major On Assessing Cardiac Function By Echocardiography And Tissue Doppler Imaging- A Hospital Based Single Blind Randomized Controlled Trialen_US
dc.typeDissertationsen_US
Appears in Collections:Pediatrics MD

Files in This Item:
File Description SizeFormat 
REG NO. BM0119007.pdf2.9 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.